key: cord-0290442-1pbo1qlb
authors: Onnis, Anna; Andreano, Emanuele; Cassioli, Chiara; Pantano, Elisa; Abbiento, Valentina; Marotta, Giuseppe; Rappuoli, Rino; Baldari, Cosima T
title: SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assembly
date: 2022-05-20
journal: bioRxiv
DOI: 10.1101/2022.05.20.492764
sha: 2a7ff1731ffa412eaec50d0a5a1facd5ee272b53
doc_id: 290442
cord_uid: 1pbo1qlb

CTL-mediated killing of virally infected or malignant cells is orchestrated at a specialized intercellular junction, the immune synapse (IS). We hypothesized that SARS-CoV-2 may target IS assembly in CTLs to escape killing. We show that primary human CD8+ T cells strongly upregulate the expression of ACE2, the Spike protein receptor, during differentiation to CTLs. CTL pre-incubation with the Wuhan or Omicron Spike variants inhibits IS assembly and function, as shown by defective synaptic accumulation of TCRs and tyrosine phosphoproteins as well as defective centrosome and lytic granule polarisation to the IS, resulting in impaired target cell killing. These defects were reversed by anti-Spike antibodies that interfere with ACE2 binding and were reproduced by ACE2 engagement with Angiotensin-II or an anti-ACE2 antibody, but not by the ACE2 product Ang (1-7). These results highlight a new strategy of immune evasion by SARS-CoV-2 based on the Spike-dependent, ACE2-mediated targeting of the lytic IS to prevent the elimination of infected cells. Summary statement We report a new mechanism of immune evasion by SARS-CoV-2 based on direct disabling CTLs to form immune synapses through Spike protein binding to ACE2. This mechanism could contribute to the failure of the immune system to control SARS-CoV-2 infection.

Severe coronavirus disease 2019 caused by SARS-CoV-2 infection is associated with immune dysregulation, with defective interferon type I response (Bastard et al., 2020; , local hyperactivation of innate immune cells and impaired adaptive immune responses, with a prominent role for T cells (Chen and John Wherry, 2020; Kalfaoglu et al., 2021) . T cell defects include lymphopenia and dysfunctions that range from excessive activation and exhaustion, to defective activation, to abnormalities in differentiation (Chen and John Wherry, 2020; Kalfaoglu et al., 2021) . Interestingly, CD8 + T cells appear preferentially dysregulated in severe COVID-19 compared to CD4 + T cells. A selective decrease in cytotoxic T lymphocytes (CTL) in the upper respiratory tract has been observed in patients with severe disease compared to patients with milder disease (Chua et al., 2020) . Additionally, a decrease in cytokine production by CD8 + T cells has been reported in severe COVID-19 , while a more robust CD8 + T cell expansion has been associated with milder disease or recovery (Liao et al., 2020; Wen et al., 2020) .

As the T cell effectors responsible for the apoptotic demise of virally infected cells, CTLs are major targets for immune evasion by viral pathogens. The killing machinery of CTLs includes the lytic granules, which are lysosome-like organelles enriched in granzymes and perforin, the recently described supramolecular attack particles (Balint et al., 2020) , and FasL, which is released both at the plasma membrane and in association with exosomes to trigger the Fas apoptosis pathway in target cells (Cassioli and Baldari, 2022) . While the specificity of killing is dependent on cognate cell recognition by T cell antigen receptor (TCR) interaction with major histocompatibility complex-bound peptide antigen (pMHC), selectivity is ensured by the precise delivery of the cytotoxic effectors to the target cell at the immune synapse (IS), a highly specialized signaling and secretory platform that forms at the CTL interface with its target (Douanne and Griffiths, 2021; Dustin and Choudhuri, 2016) .

TCR engagement triggers a profound rearrangement of receptors, adhesion molecules and signaling mediators at the target cell contact, which leads to the typical bull's eye architecture of the mature IS. A reorganization of the cytoskeleton accompanies and coordinates this process. An inward actin flow allows for the centripetal movement of TCRs and co-stimulatory receptors to the IS center, eventually forming an F-actin ring that seals a space between the CTL and its target, the synaptic cleft. Additionally, the centrosome and secretory apparatus polarise towards the synaptic membrane, with microtubules providing tracks for the transport of the cytotoxic machinery to the target cell contact and its delivery into the synaptic cleft (Blumenthal and Burkhardt, 2020; Martin-Cofreces and Sanchez-Madrid, 2018) .

The differentiation of antigen-specific CD8 + T cells to CTLs is primed in peripheral lymphoid tissues by DCs that have been activated at the site of infection. Hence the dysregulation of the CD8 + T response by SARS-CoV2 is likely to result, at least in part, from defective priming. However, following their differentiation, CTLs migrate to the site of infection, where they can be exposed to high virus concentrations. The finding that the SARS-CoV-2 receptor human angiotensin-converting enzyme 2 (ACE2) (Hoffmann et al., 2020) is expressed in activated T cells and mediates binding and internalisation of SARS-CoV-2 (Welch et al., 2022) suggests that, as a result of ACE2 engagement by the Spike protein, T cells may be directly modulated by the virus.

Here we have hypothesized that, similar to lymphotropic viruses such as HIV-1 (Fackler et al., 2007) , SARS-CoV-2 may target IS assembly and function as a means to escape CTL-mediated killing. We provide evidence that Spike suppresses IS assembly in CTLs, leading to impaired cytotoxicity. This effect is dependent on its interaction with ACE2 and can be reproduced by ACE2 ligands, highlighting a role for ligand-bound ACE2 as an inhibitory receptor in CTL activation and a target for immune evasion by SARS-CoV-2.

While activated T cells have been reported to express the Spike receptor ACE2 (Coppo et al., 2011; Welch et al., 2022) , whether this occurs in CTLs has not been investigated. We generated CTLs from CD8 + T cells immunopurified by negative selection from buffy coats from healthy donors and activated using beads coated with anti-CD3 and anti-CD28 mAbs in the presence of IL-2 (Fig.S1A ). Under these conditions CD8 + T cells differentiate to functional CTLs by day 5, as assessed by granzyme B (GzmB) expression and cytotoxicity (Fig.S1B,C) . Quantitative real-time RT-PCR showed that ACE2 was undetectable in freshly purified CD8 + T cells but was strongly upregulated in CTLs (Fig.1A ).

To test the hypothesis that Spike binding to ACE2 can modulate CTL function by targeting the IS, CTLs were pre-treated for 30 min with different concentrations of the original Wuhan Spike (Spike-W) at 20°C to allow for binding but not internalization, and subsequently mixed with Raji B cells pulsed with a mix of the Staphylococcal enterotoxins A, B and E to broadly cover the TCR Vb repertoire. This is the experimental setting typically used to image IS assembly when using polyclonal human T cells. The experiment was carried out in the absence of serum to rule out potential effects of circulating angiotensins (Ang).

The assembly of functional immune synapses was assessed by measuring the accumulation of tyrosine phosphoproteins and TCR/CD3 complexes at the T cell contact with the APC 15 min following conjugate formation, a time point when the IS has acquired its characteristic architecture. Spike was found to suppress the formation of signaling-competent immune synapses by CTLs in a dose-dependent fashion, as shown by the decreased frequency of conjugates displaying PTyr staining at the IS as well as the impairment in the synaptic accumulation of tyrosine phosphoproteins TCR signaling starts immediately upon T cell contact with a cognate APC and is sustained throughout the process of IS maturation. To understand whether Spike interferes with TCR signaling at an earlier stage of IS maturation we compared the outcome of CTL pretreatment with Spike-W on IS assembly in 5-min (nascent IS) versus 15-min (mature IS) conjugates. The defects in phosphotyrosine signaling and TCR/CD3 accumulation at the IS were clearly detectable in 5-min conjugates ( Fig.2A,B) , indicating that Spike-W impairs TCR signaling at an early step in IS formation. Consistent with this finding, the early synaptic accumulation of active ZAP-70, the protein tyrosine kinase responsible for coupling the TCR to the downstream tyrosine phosphorylation cascade (Au-Yeung et al., 2018) , was compromised in Spike-W pre-treated CTLs (Fig.2C ).

Centrosome repositioning beneath the synaptic membrane is essential for the polarized delivery of the cytotoxic effectors of CTLs to the target cell (Douanne and Griffiths, 2021) . Co-staining with anti-pericentrin and anti-GzmB Abs showed that centrosome polarization towards the IS was impaired in Spike-W-pretreated CTLs, as assessed by measuring the distance of the centrosome from the IS center ( Fig.S2A ; Fig.3A ,B; videos 4-6). Additionally, the convergence of the lytic granules towards the centrosome, which is required for efficient degranulation (Daniele et al., 2011; Mentlik et al., 2010) , was impaired under these conditions ( Fig.S2A; Fig.3A ,C; videos 4-6).

To test the outcome of this defect on CTL-mediated killing, we carried out cytotoxicity assays by incubating Spike-W-pretreated, CFSE-labelled CTLs with SAg-pulsed Raji cells for 4 h, followed by staining with propidium iodide and flow cytometric analysis, gating on the CFSE-negative cell population. Consistent with the defect in lytic granule transport to the IS, Spike-W was found to suppress the ability of CTLs to kill target cells (Fig.3D ). Hence Spike-W prevents CTLs from forming functional immune synapses, thereby compromising their killing potential.

To achieve insights into the mechanism underlying the suppressive activity of Spike on CTL IS assembly and function, we extended the analysis to the recent Spike variants Omicron BA.1 and BA.2. These variants recapitulated the effects of Spike-W on IS assembly, as assessed by measuring the synaptic accumulation of tyrosine phosphoproteins and TCR/CD3 complexes (Fig.4A ,B), as well as the polarization of the centrosome toward the IS and the convergence of lytic granules around the centrosome (Fig.4C,D) . Since the mutations carried by the Omicron Spike variants do not compromise ACE2 binding (Wrapp et al., 2020; Yin et al., 2022) , this result suggests that the effects of Spike on CTLs are mediated by ACE2. Consistent with this notion, pre-treatment of CTLs with Spike-W or Spike Omicron BA.1 in the presence of specific neutralizing mAbs that prevent Spike binding to ACE2 (Andreano et al., 2021a; Andreano et al., 2021b; Torres et al., 2022) reverted the suppressive effects of the Spike variants on IS assembly by CTLs ( Fig.4A-D) . Additionally, no effects of Spike on IS assembly were detectable in freshly purified CD8 + T cells 

ACE2 is a type I transmembrane zinc metalloprotease that plays a key role in the renin-angiotensin system (RAS). The extracellular carboxypeptidase domain of ACE2 catalyses the conversion of Angiotensin (Ang)-I to Ang (1-9), and Ang-II and Ang (1-9) to the bioactive peptide Ang (1-7) which activates the receptor MAS1 on target cells (Samavati and Uhal, 2020) . However, ACE2 also acts as a receptor that modulates intracellular processes in a peptidase-independent manner through distinct contributions of its extracellular, transmembrane and intracellular domains, including integrin transactivation, regulation of aminoacid transporters and endocytosisdependent infection by SARS-CoV-2 (Danilczyk et al., 2006; Hoffmann et al., 2020; Inoue et al., 2007; Simons et al., 2021) . The fact that mAbs that prevent Spike interaction with ACE2 reverse the effects of Spike supports the notion that the inhibitory effects on IS formation are mediated by ACE2 signaling. To test this hypothesis we assessed the outcome of ACE2 engagement on IS assembly in CTLs, using as ligand an anti-ACE2 polyclonal Ab raised against the extracellular domain that blocks SARS-CoV-2 entry in target cells by competing with Spike for ACE2 binding (Hoffmann et al., 2020) . CTL pre-treatment with the anti-ACE2 Ab recapitulated the suppressive effects of Spike on IS assembly, including the synaptic accumulation of tyrosine phosphoproteins and TCR/CD3 complexes (Fig.5A (1-7) receptor MAS1. In this context, although we found MAS1 to be expressed in CD8 + T cell, its expression decreased during their differentiation to CTLs (Fig.S3G) . Taken together, these results support the notion that, following ligand binding, ACE2 delivers inhibitory signals to suppress IS assembly.

Collectively, our data provide novel insight into the mechanisms of immune evasion by SARS-CoV-2, involving the Spike-ACE2 axis, as a means for infected cells to avoid killing. The precise mechanism underlying the inhibitory effects of Spike on IS assembly remains to be elucidated. Our data show that SARS-CoV-2 Spike protein binding to ACE2 interferes with the assembly of a functional IS in CTLs by inhibiting the process at an early step. Of note, the Omicron variants suppress IS assembly to a similar extent as Spike-W, despite a higher binding affinity for ACE2 (Wrapp et al., 2020; Yin et al., 2022) , suggesting that Spike-W binding to ACE2 is sufficient to fully unleash the inhibitory potential of ACE2 engagement on this process. Potential targets of the ACE2-Spike axis are integrins such as LFA-1, which is essential for the generation of well-structured immune synapses characterised by the tight accumulation of TCR/CD3 complexes at the center of the contact area with the APC (Cassioli et al., 2021a) . ACE2 has been reported to interact with b1 integrin, a fibronectin receptor, inducing its conversion to the open, high-affinity conformation and activation of downstream signaling mediators such as FAK (Clarke et al., 2012; Lin et al., 2004) . Whether ACE2 modulates integrin signaling in T cells is an interesting hypothesis that warrants testing.

It is noteworthy that, close to the ACE2 binding site, Spike displays a conserved RGD sequence, the consensus integrin-binding motif (Sigrist et al., 2013) . Experimental evidence supports the notion that b1 and αv integrins may act as alternative Spike receptors or co-receptors together with ACE2 (Norris et al., 2022; Park et al., 2021) .

Mechanistically, Spike has been shown to modulate b1 integrin signaling in the kidney cell line Vero E6 for productive infection by activating inside-out signaling mediated by Ga13 and the integrin adaptor talin (Simons et al., 2021) . Additionally, the RGD sequence within the ACE2-binding domain of Spike has been recently identified as an αv-selective integrin agonist in primary human airway epithelial cells, where it triggers cell spreading, formation of focal adhesions and actin reorganisation through the activation of the kinases FAK and Src, and the adaptor paxillin (Norris et al., 2022) .

However, the fact that integrin activation is a key activating event required for the onset of IS assembly (Springer and Dustin, 2012) , while Spike suppresses this process, strongly suggests that the inhibitory effects of Spike on the CTL IS are unlikely to be mediated by integrins. Additionally, our data show that the Spike Omicron BA.2 variant, which carries a non-conservative D to N substitution at position 405 of the RGD integrin binding motif mapping at positions 403-405 (RGN), is as effective as Spike-W and Spike Omicron BA-1 at suppressing IS assembly. Conversely, the ability of mAbs that prevent Spike binding to ACE2, together with the lack of any effect of Spike on IS assembly in freshly purified CD8 + T cells that do not express ACE2, highlights the key role of ACE2 in the Spike-dependent suppression of IS assembly and CTL-mediated killing.

The finding that ACE2 engagement by the ACE2 ligand Ang-II, or by an anti-ACE2 Ab specific for the extracellular domain, elicits effects that recapitulate those observed for Spike on the CTL IS further supports the notion that, upon engagement by ligand, ACE2 acts as a receptor that negatively regulates the TCR-derived signals driving CTL IS assembly. While the role of ACE2 as an ectoenzyme that participates in the RAS has been extensively characterized, the role of its transmembrane and intracellular domains, that together display 48% identity with collectrin (Zhang et al., 2001) , are only beginning to be explored. Both domains have been implicated in SARS-CoV-2 infection through the endocytic uptake of the virus following Spike-mediated binding to the extracellular domain of ACE2 (Hoffmann et al., 2020; Inoue et al., 2007) .

Additionally, the collectrin homology domain has been shown to act as a chaperone to stabilise transporters of large neutral aminoacids at the surface of intestinal epithelial cells to regulate aminoacid absorption (Camargo et al., 2009; Kowalczuk et al., 2008) . The intracellular domain also regulates the TACE/ADAM17-mediated shedding of the extracellular domain to its catalytically active soluble form by interacting with calmodulin (Lambert et al., 2008) . Whether these peptidaseindependent functions may be relevant to CTL IS assembly and target cell killing remains to be investigated.

It is noteworthy that a functional RAS has been documented in T cells (Coppo et al., 2011) . Among the RAS components, the Ang-II receptor AT1 has been reported to have immunomodulatory effects on T cells, limiting harmful CD8 + T cell responses during blood-stage malaria and promoting a protective CD4 + T cell response in the kidney in the setting of hypertension (Silva-Filho et al., 2016; Silva-Filho et al., 2017; Zhang et al., 2012) . This suggests that ACE2 may participate in T cell immunity through both its enzyme-independent and its enzyme-dependent activities.

Other viruses have co-opted the T cell IS as a target to escape immunosurveillance.

One of the most striking examples is HIV-1, which exploits the virulence factor Nef to subvert the process of vesicular trafficking required for the coordinated transport of key signaling components to the IS. The resulting IS abnormalities and signaling defects eventually lead to a nonproductive T cell response against the virus (Fackler et al., 2007) . Importantly, the IS acts a signaling and cell-cell communication platform also for other immune cells, including helper T cells and B cells (Batista et al., 2001; Chemin et al., 2012; Papa and Vinuesa, 2018) . The data reported here highlight the intriguing possibility that SARS-CoV-2 may co-opt IS targeting as a wide-ranging immunomodulatory strategy, beyond suppression of CTL function, to evade the adaptive immune response of the host.

Primary human CD8 + T cells were isolated from buffy coats of healthy donors and Alexa Fluor 488-and 555-labeled secondary antibodies were from ThermoFisher Scientific (anti-mouse 488, #A11001; anti-rabbit 555, #A21428).

Plasmids encoding the Wuhan Spike (Spike-W) Final proteins were dispensed in aliquots of 0.5 ml each and stored at -80°C prior to use.

Expi293F™ cells (Thermo Fisher) were transfected with plasmids carrying J08 and 02M04 antibody heavy and the light chains with a 1:2 ratio using ExpiFectamineTM293

Transfection Kit (Thermo Fisher Scientific) as recommended by the manufacturer.

Three and six days after transfection, cell cultures were harvested and clarified by centrifugation (1,100 g for 10 min at RT). Supernatants were recovered and filtered with 0.45 μm filter to remove particulate material. Purification process was conducted at room temperature using the ÄKTA Go purification system (GE Healthcare Life Units/mL recombinant human IL-2 for further three days (day 5). Five days postpurification, cells were further expanded for two days and collected at the day 7.

To allow for Spike binding on the cell surface, CD8 + T cells (0.5x10 6 ) were incubated for 30 min at 20°C in 50 µl RPMI-HEPES in the absence of BCS with 2.5 µg Spike Wuhan/BA.1/BA.2 or PBS vehicle control (concentration of Spike treatment chosen based on a dose-response analysis; see Figure S2B ). Spike Wuhan and the variant Omicron BA.1 were also incubated in combination with the respective neutralizing mAbs (J08 and 02M04, respectively) at a 1:3 protein:antibody ratio. Alternatively, CD8 + T cells (0.5x10 6 ) were incubated for 30 min at 20°C in 50 µl RPMI-HEPES in the absence of BCS with 2 µg/ml anti-ACE2 antibody (R&D Systems, #AF933) (Hoffmann et al., 2020) . Alternatively, cells were incubated with the ACE2 substrate/ligand Angiotensin II (Merck, #A9525; 1 µM) or the ACE2 product Ang (1-7) (Sigma, #A9202; 1 µM) in the same culture conditions described above.

For cytotoxicity assays, cells were pre-treated in the same conditions in serum-free AIM V medium (Gibc0, #12055-091). None of the treatments affected cell viability at the concentrations and times chosen for the analyses, as assessed by Trypan blue (Sigma-Aldrich, T8154) exclusion (see legend to figures 1 and 5).

Conjugates between CD8 + T cells and superantigens-pulsed Raji B cells were carried out as previously described (Cassioli et al., 2021b) . Raji B cells (0. Confocal microscopy was carried out on a Zeiss LSM700 (Carl Zeiss, Jena, Germany) microscope using a 63x/1.40 oil immersion objective. Images were acquired with pinholes opened to obtain 0.8 µm-tick sections. Detectors were set to detect an optimal signal below the saturation limits. Images were processed with Zen 2009 image software (Carl Zeiss, Jena, Germany). Immunofluorescence analyses were carried out on medial optical sections of CD8 + T cell:APC conjugates using ImageJ (version 1.53a). Relative distances (µm) of the centrosome (marked by PCNT) from the center of the contact site with the APC, and of the lytic granules (marked by GzmB) from the centrosome, were measured using ImageJ (FigS2A). Scoring of conjugates for accumulation of CD3z or P-Tyr at the IS, or for centrosome (PCNT) juxtaposition to the IS membrane, was based on the presence of the respective staining solely at the T cell-APC contact site and was expressed as percentage of conjugates with synaptic staining versus the total number of conjugates analyzed. Recruitment index was calculated for each marker as the ratio of CD3z or p-Tyr fluorescence intensity at the synaptic area, which is manually defined at the T cell-APC contact site, compared to the remaining T-cell area, using ImageJ.

Z-stacks were acquired on a spinning disk confocal and super-resolution microscope (CSU-W1-SoRA Nikon), with 60x oil objectives (numerical aperture 1.49) using a Photometrics BSI (Nikon). 3D Deconvolution (Richardson-Lucy method, 10 iterations) was applied to high-resolution imaging to improve contrast of video 2 and 3. 3D reconstructions were obtained using Fiji (version 2.1.0).

RNA was extracted from CTLs (days 0, 5 and 7) using the RNeasy Plus Mini Kit (Qiagen. #74136), reverse transcribed to first-strand cDNAs using iScript™ cDNA Synthesis Kit (Bio-Rad, #1708891) and analyzed by Real-time quantitative PCR (RT-qPCR) as previously described (Onnis et al., 2015) . 

Each experiment was performed at least 3 independent times. The exact number of repeats and the number of cells analyzed is specified in the figure legends. Statistical analyses were performed with Prism software (GraphPad Software n.s., not significant.

Included in the supplemental material are three supplementary figures showing the workflow for CTL generation (Fig.S1 ), a comparison of the effects of Spike-W on IS signaling in freshly purified and day-7 CD8 + T cells (Fig.S2) , and the effects of anti-ACE2 mAb on the nascent and mature IS in CTLs (Fig.S3) . harboring PTyr staining at the IS (≥50 cells/sample, n=3, One-way ANOVA test). Right,

Extremely potent human monoclonal antibodies from COVID-19 convalescent patients

Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants

ZAP-70 in Signaling, Biology, and Disease

Supramolecular attack particles are autonomous killing entities released from cytotoxic T cells

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

B cells acquire antigen from target cells after synapse formation

Multiple actin networks coordinate mechanotransduction at the immunological synapse

Tissuespecific amino acid transporter partners ACE2 and collectrin differentially interact with hartnup mutations

The Expanding Arsenal of Cytotoxic T Cells

Increasing LFA-1 Expression Enhances Immune Synapse Architecture and

The Bardet-Biedl syndrome complex component BBS1 controls T cell polarity during immune synapse assembly

Cytokine secretion by CD4+ T cells at the immunological synapse requires Cdc42-dependent local actin remodeling but not microtubule organizing center polarity

T cell responses in patients with COVID-19

COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis

Angiotensin converting enzyme (ACE) and ACE2 bind integrins and ACE2 regulates integrin signalling

Ang II Upregulation of the T-lymphocyte reninangiotensin system is amplified by low-grade inflammation in human hypertension

A role for Rab7 in the movement of secretory granules in cytotoxic T lymphocytes

Essential role for collectrin in renal amino acid transport

Cytoskeletal control of the secretory immune synapse

Signaling and Polarized Communication Across the T Cell Immunological Synapse

Modulation of the immunological synapse: a key to HIV-1 pathogenesis?

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2

Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted

T-cell dysregulation in COVID-19

A protein complex in the brush-border membrane explains a Hartnup disorder allele

A simple, economic, time-resolved killing assay

Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2) and inhibits shedding of its ectodomain

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

Interaction of ACE2 and integrin beta1 in failing human heart

Sailing to and Docking at the Immune Synapse: Role of Tubulin Dynamics and Molecular Motors

Rapid lytic granule convergence to the MTOC in natural killer cells is dependent on dynein but not cytolytic commitment

Receptor binding domain of SARS-CoV-2 is a functional alphav-integrin agonist

The small GTPase Rab29 is a common regulator of immune synapse assembly and ciliogenesis

Synaptic Interactions in Germinal Centers

The Spike Glycoprotein of SARS-CoV-2 Binds to beta1 Integrins Expressed on the Surface of Lung Epithelial Cells

Much More Than Just a Receptor for SARS-COV-2

New and continuing developments at PROSITE

Angiotensin II type-1 receptor (AT1R) regulates expansion, differentiation, and functional capacity of antigen-specific CD8(+) T cells

Targeting Angiotensin II Type-1 Receptor (AT1R) Inhibits the Harmful Phenotype of Plasmodium-Specific CD8(+) T Cells during Blood-Stage Malaria

Integrin activation is an essential component of SARS-CoV-2 infection

Integrin inside-out signaling and the immunological synapse

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

T-Cell Expression of Angiotensin-Converting Enzyme 2 and Binding of Severe Acute Respiratory Coronavirus 2

Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody

Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys

A novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Functional exhaustion of antiviral lymphocytes in COVID-19 patients

cells/sample, n=3, Kruskal-Wallis test). D. Left, Quantification (%) of 15-min antigen-specific conjugates harboring CD3z staining at the IS (≥50 cells/sample, n=3, One-way ANOVA test)

PBS) or 0.05µg/µl Spike Wuhan (Spike W), mixed with Raji cells (APCs) either unpulsed or pulsed with a combination of SEA, SEB and SEE (SAgs), and incubated for 15 min at 37°C (10 cells/sample, n=3, Kruskal-Wallis test)

01; *p≤0.05. Non-significant differences are not shown

CD3ζ (B), or P-ZAP-70 (C) staining at the IS in CTLs (day 7) pre-treated with either vehicle (PBS) or 0.05µg/µl Spike Wuhan (Spike W), then mixed with Raji cells (APCs) either unpulsed or pulsed with a combination of SEA, SEB and SEE (SAgs), and incubated for 15 min at 37°C (≥50 cells/sample, n=3, One-way ANOVA test). Right, Relative PTyr (A), CD3ζ (B), or P-ZAP-70 (C) fluorescence intensity at the IS (recruitment index

01; *p≤0.05. Non-significant differences are not shown

Figure 3. Spike inhibits centrosome and lytic granule polarisation to the CTL IS and CTL-mediated cytotoxicity. A-C. Immunofluorescence analysis of PCNT and GrzmB in CTLs (day 7) pre-treated with either vehicle (PBS) or 0.05µg/µl Spike Wuhan (Spike W), then mixed with Raji cells (APCs) either unpulsed or pulsed with a combination of SEA, SEB and SEE (SAgs), and incubated for 15 min at 37°C. Representative images (medial optical sections

Quantification (%) of 15-min antigen-specific conjugates harboring PCNT staining at the IS (≥50 cells/sample, n=3, One-way ANOVA test). Right, Measurement of the distance (µm) of the centrosome (PCNT) from the CTL-APC contact site

D. Flow cytometry analysis of cytotoxicity of CTLs (day 7) pretreated with either vehicle (PBS) or Spike Wuhan (Spike W). Left, Representative flow cytometric dot plot showing the percentages (%) of CFSE -/PI + cells. Right, Quantitative analysis of CTL-mediated cytotoxicity of Raji B cells. The histograms show the percentage (%) of target cells lysed (n=4, unpaired two-tailed Student's t-test). Values for the treatment with vehicle were set as 100%

01; *p≤0.05. Non-significant differences are not shown

Inhibition of CTL IS assembly by Spike-W or the Omicron BA.1 and BA.2 variants can be reversed by mAbs that interfere with ACE2 binding

Quantification (%) of 15-min antigen-specific conjugates harboring PTyr (A) or

CD3ζ (B) staining at the IS in CTLs (day 7) pre-treated with either vehicle (PBS) or

Spike Omicron BA.1 (Spike BA.1), alone or in the presence of the respective neutralizing mAb

1+02M04); or

Samples pre-treated with only the neutralizing mAbs (J08 and 02M04) were also included in the analysis. CTLs were mixed with Raji cells (APCs), either unpulsed or pulsed with a combination of SEA, SEB and SEE (SAgs), and incubated for 15 min at 37°C

cells/sample, n=3, Kruskal-Wallis test). C. Left, Quantification (%) of 15-min antigen-specific conjugates formed as in panel A harboring PCTN1 staining at the IS (≥50 cells/sample, n=3, One-way ANOVA test). Right, Measurement of the distance (µm) of the centrosome (PCNT) from the T cell-APC contact site (10 cells/sample, n=3, Kruskal-Wallis test). D. Measurement of the distance (µm) of the lytic granules (LG, marked by GzmB) from the centrosome (PCNT) in 15-min antigenspecific conjugates

01; *p≤0.05. Non-significant differences are not shown

Figure 5. The inhibitory effects of Spike on IS formation are mediated by ACE2

Quantification (%) of 15-min conjugates harboring PTyr (A) or CD3ζ (B) staining at the IS. CTLs (day 7) were conjugated with Raji cells (APCs) in the absence or presence of SAgs and either an anti-ACE2 Ab

One-way ANOVA test). Right, Relative PTyr (A) or CD3ζ (B) fluorescence intensity at the IS (recruitment index) (10 cells/sample, n=3, Kruskal-Wallis test). C. Left, Quantification (%) of 15-min conjugates formed as in panel A harboring PCTN staining at the IS

Kruskal-Wallis test). D. Measurement of the distance (µm) of the lytic granules (LG, marked by GzmB) from the centrosome (PCNT) in 15-min CTL-APC conjugates formed as in panel A (10 cells/sample, n=3, Kruskal-Wallis test). E. Left, Flow cytometry analysis of cytotoxicity of CTLs (day 7) pre-treated with either vehicle (PBS) or 2 µg/ml anti-ACE2 Ab (ACE2). Left, Representative flow cytometric dot plot showing the percentages (%) of CFSE -/PI + cells. Right, Quantitative analysis of CTL-mediated cytotoxicity of Raji B cells. The histograms show the percentage (%) of target cells lysed (n=4, unpaired two-tailed Student's t-test). Values for the treatment

01; *p≤0.05. Non-significant differences are not shown